Sana Biotechnology SANA
NASDAQ SANA
$2.91 -0.02 (-0.68%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sana Biotechnology (SANA) Common Equity (2020 - 2026)

Updated

Sana Biotechnology (SANA) posted Common Equity of $154.57 million for Q2 2026, up 26.1% from $122.56 million a year earlier and up 29.6% from the prior quarter.

Analysis

Sana Biotechnology (SANA) Common Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Sana Biotechnology's Common Equity came in at $160.88 million, down 35.8% from FY2024.

  • Annual Common Equity has declined for four consecutive years.
  • In prior years, Sana Biotechnology's Common Equity was $250.5 million in FY2024 (-12.9%), $287.51 million in FY2023 (-42.4%), $499.32 million in FY2022 (-31.5%) and $728.5 million in FY2021.
  • Quarterly Common Equity has run from a low of $119.24 million in Q1 2026 to a high of $830.09 million in Q3 2021 over five years.
  • On a year-over-year basis, Common Equity increased in 1 of the last eight quarters, with an average decline of 28.4%.
  • The strongest year-over-year quarter for Common Equity in the past five years was Q2 2026, with growth of 26.1%; the weakest was Q2 2025, with a decline of 63.9%.
  • According to Business Quant data, Common Equity for the three prior quarters was $119.24 million (Q1 2026), $160.88 million (Q4 2025) and $195.31 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Sana Biotechnology 876.97 Mn 876.97 Mn - 154.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 154.57 Mn
Mar 31, 2026 119.24 Mn
Dec 31, 2025 160.88 Mn
Sep 30, 2025 195.31 Mn
Jun 30, 2025 122.56 Mn
Mar 31, 2025 209.08 Mn
Dec 31, 2024 250.50 Mn
Sep 30, 2024 292.48 Mn
Jun 30, 2024 339.65 Mn
Mar 31, 2024 375.14 Mn
Dec 31, 2023 287.51 Mn
Sep 30, 2023 365.85 Mn
Jun 30, 2023 355.03 Mn
Mar 31, 2023 428.26 Mn
Dec 31, 2022 499.32 Mn
Sep 30, 2022 566.02 Mn
Jun 30, 2022 639.51 Mn
Mar 31, 2022 701.66 Mn
Dec 31, 2021 728.50 Mn
Sep 30, 2021 830.09 Mn
API Access

Sana Biotechnology Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=SANA&period=max&api_key=YOUR_API_KEY